Live feed08:00:00·184dPRReleasevia QuantisnowGrace Therapeutics Secures Approximately $4.0 Million through Common Warrant Exercises Following Acceptance of New Drug Application for GTx-104 for formal FDA ReviewByQuantisnow·Wall Street's wire, on your screen.GRCE· Grace Therapeutics Inc.Health Care
